Incremental Versus Standard (Full-Dose) Peritoneal Dialysis
- PMID: 35155856
- PMCID: PMC8820986
- DOI: 10.1016/j.ekir.2021.11.019
Incremental Versus Standard (Full-Dose) Peritoneal Dialysis
Abstract
Incremental peritoneal dialysis (PD), defined as less than "standard dose" PD prescription, has a number of possible benefits, including better preservation of residual kidney function (RKF), reduced risk of peritonitis, lower peritoneal glucose exposure, lesser environmental impact, and reduced costs. Patients commencing PD are often new to kidney replacement therapy and possess substantial RKF, which may allow safe delivery of an incremental prescription, often in the form of lower frequency or duration of PD. This has the potential to help improve quality of life (QOL) and life participation through reducing time requirements and burden of treatment. Alternatively, incremental PD could potentially contribute to reduced small solute clearance, fluid overload, or patient reluctance to increase dialysis prescription when later needed. This review discusses the definition, rationale, uptake, potential advantages and disadvantages, and clinical trial evidence pertaining to the use of incremental PD.
Keywords: incremental dialysis; patient-centered care; peritoneal dialysis; personalized medicine; quality of life.
© 2021 International Society of Nephrology. Published by Elsevier Inc.
Figures
References
-
- Fresenius annual report 2020 Fresenius Medical Care. https://www.fresenius.com/media_library/Fresenius_Annual_Report_2020.pdf Published 2020. Accessed April 15, 2021.
-
- Lai K.N., Lo W.K. Optimal peritoneal dialysis for patients from Hong Kong. Perit Dial Int. 1999;19(suppl 3):S26–S34. - PubMed
Publication types
LinkOut - more resources
Full Text Sources